A Panel Of Overexpressed Proteins For Prognosis In Esophageal Squamous Cell Carcinoma

Li Shang,Hui-Juan Liu,Jia-Jie Hao,Yan-Yi Jiang,Feng Shi,Yu Zhang,Yan Cai,Xin Xu,Xue-Mei Jia,Qi-Min Zhan,Ming-Rong Wang
DOI: https://doi.org/10.1371/journal.pone.0111045
IF: 3.7
2014-01-01
PLoS ONE
Abstract:Esophageal squamous cell carcinoma (ESCC) is a common cancer with poor prognosis. In order to identify useful biomarkers for accurately classifying prognostic risks for ESCC patients, we examined the expression of six proteins by immunohistochemistry (IHC) in 590 paraffin-embedded ESCC samples. The candidate proteins include p53, EGFR, c-KIT, TIMP1 and PI3K-p110 alpha reported to be altered in ESCC tissues as well as another important component of PI3K, PI3K-p85 alpha. Of the six proteins tested, p53, EGFR, c-KIT, TIMP1 and PI3K-p85 alpha were detected with high expression in 43.0%, 36.6%, 55.9%, 70.7% and 57.1% of tumors, respectively. Significant associations were found between high expression of PI3K-p85 alpha, EGFR and p53 and poor prognosis (P = 0.00111; 0.00001; 0.00426). Applying these three proteins as an IHC panel could divide patients into different subgroups (P<0.000001). Multivariate cox regression analysis indicated that the three-protein panel was an independent prognostic factor with very high statistical significance (HR = 2.090, 95% CI: 1.621-2.696, P = 0.00000001). The data suggest that the protein panel of PI3K-p85 alpha, EGFR and p53 is an important candidate biomarker for the prognosis of patients with ESCC.
What problem does this paper attempt to address?